Carl A. Huffman

FDA investigator

Appears on 11 documents from 2015 to 2026, most often at sites in Kansas. Most often cites production record review (21 CFR 211.192).

11
Documents on file
5.5
Observations per 483
2015
First seen
2026
Most recent

What they cite most

From 61 observations

Activity by year

2015: 1, 2016: 1, 2018: 1, 2020: 1, 2021: 6, 2026: 1

Where

Kansas 4 · Missouri 3 · Kentucky 2 · Iowa 1 · Nebraska 1

Is Carl A. Huffman coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Staska Pharmaceuticals, Inc.Feb 20, 2026 · Bennet, Nebraska
483 Hillyard GMPOct 8, 2021 · Saint Joseph, Missouri
483 Ceela NaturalsAug 31, 2021 · Louisville, Kentucky
483 New Vitalis Pharmacy LLCAug 27, 2021 · Louisville, Kentucky
483 Nostrum Laboratories, Inc.Apr 21, 2021 · Kansas City, Missouri
483 Eco Lips, Inc.Mar 31, 2021 · Cedar Rapids, Iowa
483 Sparhawk Laboratories, Inc.Mar 23, 2021 · Lenexa, Kansas

About this profile

What does Carl A. Huffman inspect?

Carl A. Huffman appears on 11 documents on file covering 10 sites, most often in Kansas.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and FDCA 501(a)(2)(A).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Carl A. Huffman is dated Feb 20, 2026.